Sun Pharma Q2 Profit Up 28% to Rs 3,040 cr
By Rediff Money Desk, New Delhi Oct 28, 2024 15:27
Sun Pharma reports a 28% rise in net profit to Rs 3,040 crore in the September quarter, driven by strong sales and a strengthened specialty pipeline.
New Delhi, Oct 28 (PTI) Sun Pharmaceutical Industries on Monday reported a 28 per cent increase in its consolidated net profit to Rs 3,040 crore in the September quarter.
The drug major had posted a net profit of Rs 2,375 crore in the July-September quarter of last fiscal.
Total income rose to Rs 13,645 crore in the second quarter compared to Rs 12,486 crore in the year-ago period, the Mumbai-based drug major said in a regulatory filing.
"Sun has recently strengthened its specialty pipeline through an agreement with Philogen for commercialising late stage candidate Fibromun, upon approval," Dilip Shanghvi, Chairman and Managing Director of the company, said.
With Fibromun, the company's product basket for dermatologists has expanded further, he added.
"We shall continue to leverage our strong cash position to strengthen our pipeline with products that are close to market," Shanghvi said.
Shares of the company were trading 2.22 per cent higher at Rs 1,901.55 apiece on the BSE.
The drug major had posted a net profit of Rs 2,375 crore in the July-September quarter of last fiscal.
Total income rose to Rs 13,645 crore in the second quarter compared to Rs 12,486 crore in the year-ago period, the Mumbai-based drug major said in a regulatory filing.
"Sun has recently strengthened its specialty pipeline through an agreement with Philogen for commercialising late stage candidate Fibromun, upon approval," Dilip Shanghvi, Chairman and Managing Director of the company, said.
With Fibromun, the company's product basket for dermatologists has expanded further, he added.
"We shall continue to leverage our strong cash position to strengthen our pipeline with products that are close to market," Shanghvi said.
Shares of the company were trading 2.22 per cent higher at Rs 1,901.55 apiece on the BSE.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.25 (+ 7.56)
- 69420086
- GTL Infrastructure
- 1.96 ( -1.01)
- 47792089
- Srestha Finvest
- 0.63 ( -4.55)
- 39336100
- YES Bank Ltd.
- 20.56 (+ 5.98)
- 31525072
- G G Engineering
- 2.06 ( -3.29)
- 29768305
MORE NEWS
Dr Reddy's Launches New Drug for Chronic...
Dr Reddy's Laboratories has launched BixiBat, a first-in-class drug for chronic...
Goyal's China Blockage Chat with German Vice...
Commerce Minister Piyush Goyal's conversation with German Vice Chancellor Robert Habeck...
Air India Gets DGCA Nod for In-House Aircraft...
Air India receives DGCA approval for in-house modifications of aircraft interiors,...